Dermata Therapeutics, Inc. (DRMA) SEC Filings https://ir.dermatarx.com/sec-filings/all-sec-filings/rss Dermata Therapeutics, Inc. (DRMA) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/dermatarx/files/theme/images/logo-sm.png Dermata Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0000921895-26-001059/0000921895-26-001059.pdf Wed, 22 Apr 26 16:20:37 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0000921895-26-001059/0000921895-26-001059.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-017912/0001493152-26-017912.pdf Fri, 17 Apr 26 17:05:49 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-017912/0001493152-26-017912.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-017911/0001493152-26-017911.pdf Fri, 17 Apr 26 17:03:57 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-017911/0001493152-26-017911.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-017909/0001493152-26-017909.pdf Fri, 17 Apr 26 17:01:56 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-017909/0001493152-26-017909.pdf <![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-015348/0001493152-26-015348.pdf Tue, 07 Apr 26 06:02:03 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-015348/0001493152-26-015348.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012992/0001493152-26-012992.pdf Thu, 26 Mar 26 17:21:59 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012992/0001493152-26-012992.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012991/0001493152-26-012991.pdf Thu, 26 Mar 26 17:17:29 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-012991/0001493152-26-012991.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-010630/0001493152-26-010630.pdf Tue, 17 Mar 26 17:44:47 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-010630/0001493152-26-010630.pdf <![CDATA[8-K - Current report]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-008037/0001493152-26-008037.pdf Wed, 25 Feb 26 16:10:03 -0500 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-008037/0001493152-26-008037.pdf <![CDATA[SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership]]> https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-007792/0001493152-26-007792.pdf Tue, 14 Apr 26 13:19:51 -0400 https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-007792/0001493152-26-007792.pdf